HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preservation of allergic contact dermatitis to poison ivy (urushiol) in late HIV disease. The implications and relevance to immunotherapy with contact allergens.

AbstractBACKGROUND:
Delayed hypersensitivity reactions (DTH) are lost with progression of HIV disease. This loss of DTH commonly occurs before the onset of opportunistic infections and is an independent predictor of disease progression.
OBJECTIVE:
We wanted to determine whether patients in late HIV disease with a history of allergic contact dermatitis (ACD) to poison ivy continue to react to poison ivy.
METHODS:
Twelve HIV+ patients with a past history of ACD to poison ivy were tested with an extract prepared from poison ivy leaves. All but 1 patient had CD4+ T cell counts < 200/microliters, and 5 patients had had an opportunistic infection.
RESULTS:
All 12 patients showed positive reactions ranging from mild erythema and infiltration to marked erythema with bulla formation.
CONCLUSIONS:
ACD is considered a variant of DTH, and as DTH results in a T helper 1 cytokine pattern. However, the antigen-specific effector cells in ACD may be more diverse than in DTH. This diversity could explain the continued reaction to some contact allergens in late disease and may be important in the use of contact allergens for immunotherapy.
AuthorsK J Smith, H G Skelton, A Nelson, K F Wagner, B E Hackley Jr
JournalDermatology (Basel, Switzerland) (Dermatology) Vol. 195 Issue 2 Pg. 145-9 ( 1997) ISSN: 1018-8665 [Print] Switzerland
PMID9310722 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Catechols
  • urushiol
Topics
  • Catechols (administration & dosage, immunology)
  • Dermatitis, Allergic Contact (immunology)
  • Dose-Response Relationship, Drug
  • HIV Infections (immunology)
  • Humans
  • Hypersensitivity, Delayed (immunology)
  • Immunotherapy
  • Male
  • Patch Tests
  • Plants, Toxic
  • Toxicodendron (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: